Presence of Panel-reactive Antibodies after Penetrating Keratoplasty-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Presence of Panel-reactive Antibodies after Penetrating Keratoplasty

Published:2022-04-11 Issue:4 Volume:31 Page:741-747
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Cheung Albert Y.¹,Jeffrey Joseph H.²,Kurji Khaliq H.³,Denny Matthew R.²,Govil Amit⁴,Holland Edward J.²

Affiliation:

1. Department of Ophthalmology, Virginia Eye Consultants/CVP Physicians, Norfolk, Virginia, USA

2. Department of Ophthalmology, Cincinnati Eye Institute/CVP Physicians/University of Cincinnati, Cincinnati, Ohio, USA

3. Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alberta, Canada

4. Division of Nephrology and Hypertension, University of Cincinnati, Cincinnati, Ohio, USA

Funder

Richard Lindstrom Research

Eye Bank Association of America

Alcon Laboratories, Allergan, Bausch & Lomb, Kala Pharmaceuticals, Mati Pharmaceuticals, and Senju Pharmaceuticals

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2022.2060263

Reference24 articles.

1. Long-term graft survival after penetrating keratoplasty

2. Penetrating keratoplasty: indications over a 10 year period

3. Immune Privilege of Corneal Allografts

4. Matching for Human Leukocyte Antigens (HLA) in corneal transplantation – To do or not to do

5. The Impact of Corneal Allograft Rejection on the Long-Term Outcome of Corneal Transplantation

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply;Cornea;2023-11-03

2. Why Are Corneal Specialists Resistant to Treating Patients Who Have Severe Ocular Surface Disease With Limbal Stem Cell Deficiency?;Cornea;2023-06-08

3. Immunosuppressive Therapy for High-Risk Corneal Transplant;Current Ophthalmology Reports;2022-11-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3